Today: 7 February 2026
Subscribe
Browse Category

Stock Market News 10 November 2025

Siemens Energy Hits Record Highs as Analysts Boost Targets: How AI, Grid Demand and a Wind Turnaround Drive the Stock Rally

Siemens Energy Soars After Jefferies Upgrade to €134; Commerzbank Jumps on Deutsche Bank ‘Buy’ as DAX Closes +1.65% (Nov 10, 2025)

Published: Monday, 10 November 2025 German equities rallied to start the week, led by Siemens Energy and Commerzbank after fresh analyst upgrades propelled both stocks to the top of the DAX. The benchmark index finished up 1.65% at 23,959.99, aided by broader risk-on sentiment as investors bet on progress in the U.S. budget impasse. Investing.com Deutsch Key takeaways Siemens Energy leads after Jefferies calls for €134 target Siemens Energy (Xetra: ENR) rallied after Jefferies shifted its rating to “Buy” and more than doubled its price target to €134. Analyst Lucas Ferhani argued the company’s product portfolio is positioned against the
10 November 2025
···
Eli Lilly (LLY) Pops on Fresh Deal Spree: MeiraGTx Gene Therapy Tie‑Up, New AI Collaboration, and Leerink Upgrade — Nov. 10, 2025

Eli Lilly (LLY) Pops on Fresh Deal Spree: MeiraGTx Gene Therapy Tie‑Up, New AI Collaboration, and Leerink Upgrade — Nov. 10, 2025

Eli Lilly and Company (NYSE: LLY) opened the week with a burst of dealmaking and Wall Street momentum. The pharma giant announced a rights deal for a pediatric blindness gene therapy from MeiraGTx, unveiled a new AI‑driven discovery partnership, and captured an analyst upgrade with a higher price target—moves that had LLY trading sharply higher intraday. Reuters+2 Today’s headlines at a glance Why the MeiraGTx move matters The MeiraGTx alliance hands Lilly a potential first‑in‑class therapy for LCA4 that, in a small study, has shown the ability to restore visual function in children born legally blind (regulators are evaluating expedited
10 November 2025
···
Viasat (VSAT) Soars to a 52‑Week High on Analyst Upgrade; Earnings Beat and ViaSat‑3 F2 Launch Delay in Focus — Nov 10, 2025

Viasat (VSAT) Soars to a 52‑Week High on Analyst Upgrade; Earnings Beat and ViaSat‑3 F2 Launch Delay in Focus — Nov 10, 2025

Viasat, Inc. (NASDAQ: VSAT) rallied to a new 52‑week high on Monday after a fresh Outperform upgrade and $52 price target from Raymond James. The move extends gains from Friday’s Q2 FY2026 results, which showed an adjusted EPS beat and narrowing losses. Meanwhile, the ViaSat‑3 F2 satellite launch remains scrubbed pending a new date after back‑to‑back attempts last week. ulalaunch.com+4Investing.com+4Finviz+4 Today’s key developments (Nov 10, 2025) Earnings recap: Q2 FY2026 (reported Nov 7) Why it matters: The EPS beat—despite a slight revenue miss—supports the earnings‑power narrative as the company works through integration and capacity additions from the Inmarsat portfolio and
10 November 2025
···
SoFi Technologies (SOFI) Stock Today — November 10, 2025: Price Action, Fresh 13F Moves, and What to Watch Next

SoFi Technologies (SOFI) Stock Today — November 10, 2025: Price Action, Fresh 13F Moves, and What to Watch Next

At a glance (Nov. 10, 2025) SOFI stock price today (real‑time snapshot) As of 15:49 UTC on Monday, Nov. 10, 2025, SoFi Technologies (NASDAQ: SOFI) was changing hands near $29–30, after opening at $29.06 and trading between $28.83 and $30.13 intraday on more than 33 million shares. TipRanks flagged elevated volatility and brisk options activity around SOFI today, noting a recent pullback after a strong rally and heavy call volume—context for the choppy tape. TipRanks Fresh items dated November 10, 2025 1) Institutional flows: Mitsubishi UFJ adds; Grange trims Why it matters: Rapid price moves often coincide with headline “position
10 November 2025
···
Stocks Today (Nov. 10, 2025): Nvidia Leads Big‑Tech Rebound; Futures Rise as Senate Moves to End Record Shutdown

Stocks Today (Nov. 10, 2025): Nvidia Leads Big‑Tech Rebound; Futures Rise as Senate Moves to End Record Shutdown

Big Tech snapped back to start the week as hopes for a Washington deal brightened the outlook and volatility eased. Here’s what moved markets today—Monday, November 10, 2025. What’s driving the move 1) Washington tailwinds: Senate procedural win Markets reacted to signs of progress toward ending the 40‑day government shutdown, the longest on record, after senators advanced a House‑passed bill that would fund the government into late January. Traders welcomed the possibility that official economic data could resume, helping the Federal Reserve and investors regain a clearer read on growth and inflation. Reuters 2) AI and megacaps reassert leadership Nvidia
10 November 2025
····
VTI & VOO Today (Nov. 10, 2025): Vanguard’s Broad‑Market ETFs Edge Higher on Shutdown Optimism—Latest Moves, Flows, and Why Young Investors Still Favor Them

VTI & VOO Today (Nov. 10, 2025): Vanguard’s Broad‑Market ETFs Edge Higher on Shutdown Optimism—Latest Moves, Flows, and Why Young Investors Still Favor Them

In Monday trading (Nov. 10, 2025), Vanguard’s Total Stock Market ETF (VTI) and S&P 500 ETF (VOO) ticked higher alongside equities as progress toward a U.S. government‑funding deal buoyed sentiment. As of ~15:24 UTC, VTI traded around $333.79 (≈+1.1% on the day). Markets were mixed to modestly positive, with the S&P 500 up ~0.1% and the Nasdaq down ~0.2% on the session. Nasdaq+1 What’s moving VTI and VOO today Fresh data points on VTI (Nov. 10) TipRanks’ VTI ETF Daily Report (11/10/2025) highlights that: Why it matters: The combination of continued leadership from mega‑cap tech plus steady net inflows reinforces
10 November 2025
···
Palantir (PLTR) Jumps as Burry–Karp Spat Heats Up: Fresh Q3 Numbers, Lofty Valuation, and the Bull‑vs‑Bear Case — Nov. 10, 2025

Palantir (PLTR) Jumps as Burry–Karp Spat Heats Up: Fresh Q3 Numbers, Lofty Valuation, and the Bull‑vs‑Bear Case — Nov. 10, 2025

Palantir stock is trading higher today after a bruising post‑earnings pullback last week, even as Wall Street remains sharply divided over the AI contractor’s sky‑high valuation. What’s new today (Nov. 10) Q3 by the numbers: acceleration across the board Palantir’s Q3 revenue rose 63% year over year to $1.18B, with U.S. commercial revenue up 121% to $397M and U.S. government revenue up 52% to $486M—a mix shift the company says is being propelled by its AI Platform (AIP). Slides also highlight a Rule‑of‑40 score of 114% and U.S. commercial total contract value (TCV) of $1.3B, +342% y/y. investors.palantir.com+3Reuters+3investors.palantir.com+3 Guidance: Management
10 November 2025
····
VGT vs. XLK Today (Nov. 10, 2025): Tech ETF Sell‑Off, Rebound, and Whether to Cut or Double Down

VGT vs. XLK Today (Nov. 10, 2025): Tech ETF Sell‑Off, Rebound, and Whether to Cut or Double Down

Tech’s rough first week of November gave way to a rebound today. We break down what’s moving the Vanguard Information Technology ETF (VGT) and the Technology Select Sector SPDR (XLK), how they differ under the hood, and what fresh research says about concentration risk, costs, and diversification. Key takeaways Why today matters What the latest research says about VGT and XLK (Nov. 2025) Bottom line from the coverage: breadth versus precision. VGT’s bigger roster can smooth single‑name shocks, while XLK is a pure S&P 500 tech‑sector slice with laser‑focused large‑cap exposure. Under the hood: where VGT and XLK really differ
10 November 2025
····
Vivakor (VIVK) Executes $23M LPG Trade Under $40M Credit Facility — What It Means for Investors Today (Nov. 10, 2025)

Vivakor (VIVK) Executes $23M LPG Trade Under $40M Credit Facility — What It Means for Investors Today (Nov. 10, 2025)

What happened today (Nov. 10, 2025) Vivakor, Inc. (Nasdaq: VIVK) announced that its trading arm, Vivakor Supply & Trading, has kicked off its first LPG transaction—approximately $23 million in contract value—under the company’s $40 million intermediation credit facility. Management framed the deal as a “significant operational milestone” that expands the platform into broader petroleum commodities while relying on Vivakor’s logistics and midstream footprint for transportation, gathering and execution. GlobeNewswire Why it matters How today’s news fits the recent timeline By the numbers Market reaction & read-through Shares of VIVK are higher today on the announcement. The investment takeaway is less
10 November 2025
····
Metsera (MTSR) Sinks as Pfizer Seals Revised $10B Buyout; 8‑K Spells Out $65.60 Cash + Up to $20.65 CVR — Nov. 10, 2025

Metsera (MTSR) Sinks as Pfizer Seals Revised $10B Buyout; 8‑K Spells Out $65.60 Cash + Up to $20.65 CVR — Nov. 10, 2025

Shares of Metsera, Inc. (NASDAQ: MTSR) slumped on Monday after the obesity‑drug developer said it will proceed with a sweetened takeover by Pfizer that ends a high‑stakes bidding war with Novo Nordisk. Metsera accepted Pfizer’s revised offer late Friday; Novo dropped out over the weekend. In early U.S. trading today, MTSR fell ~15% as investors recalibrated expectations around the final deal structure. Key takeaways (Nov. 10) What changed today The revised terms, line by line (from today’s 8‑K) Metsera’s Form 8‑K filed this morning lays out material changes versus the September agreement: Why Novo bowed out — and the FTC’s
10 November 2025
···
Cogent Biosciences (COGT) soars ~115% after PEAK Phase 3 shows 16.5‑month PFS in GIST; NDA targeted for 1H 2026 (Nov. 10, 2025)

Cogent Biosciences (COGT) soars ~115% after PEAK Phase 3 shows 16.5‑month PFS in GIST; NDA targeted for 1H 2026 (Nov. 10, 2025)

Cogent Biosciences (NASDAQ: COGT) announced positive top‑line results from its Phase 3 PEAK trial testing bezuclastinib plus sunitinib in second‑line gastrointestinal stromal tumor (GIST), sending the stock sharply higher in Monday trading. The combination delivered a median progression‑free survival (mPFS) of 16.5 months vs. 9.2 months for sunitinib alone (HR=0.50; 95% CI 0.39–0.65; p<0.0001) and a 46% objective response rate vs. 26% on sunitinib monotherapy (p<0.0001). GlobeNewswire “It is a historic day for Cogent Biosciences and the GIST patient community,” CEO Andrew Robbins said, adding that the bezuclastinib combination “is poised to become the new standard of care” in second‑line
10 November 2025
···
IMTE Stock Today: Nasdaq Delisting Clock Hits Nov. 10—Shares Trade as Hearing Stay Appears in Effect

IMTE Stock Today: Nasdaq Delisting Clock Hits Nov. 10—Shares Trade as Hearing Stay Appears in Effect

Integrated Media Technology Limited (NASDAQ: IMTE) faced a scheduled Nasdaq suspension and delisting on Nov. 10, 2025, over a late 20‑F. Shares were trading at the open, suggesting a short automatic stay tied to a Nasdaq hearing request. Here’s the status, timeline, and what investors should watch next. Key takeaways Stock snapshot (intraday) As of ~14:34 UTC (9:34 a.m. ET), IMTE was actively trading with heavy volume. At a glance: Price ~$1.06; day’s range ~$0.88–$2.32; intraday volume ~51.8M. (Live exchange data via widget above.) What happened and when (the timeline) Editor’s context: Several outlets and market pages recapped the Oct.
10 November 2025
··
1 … 1,716 1,717 1,718 1,719 1,720 … 1,916

Stock Market Today

ST Engineering stock price drops 2% to S$9.71 as drone-autonomy tie-up grabs attention

ST Engineering stock price drops 2% to S$9.71 as drone-autonomy tie-up grabs attention

7 February 2026
ST Engineering shares fell 1.9% to S$9.71 Friday, outpacing the Singapore market’s 0.8% drop amid a tech-led selloff. The company signed a deal with Shield AI at the Singapore Airshow to integrate autonomy software into its unmanned platforms and unveiled a small drone capable of carrying explosives. About 6.9 million shares traded as investors await full-year results on Feb. 27.
Go toTop